1) umbilical cord blood stem cell transplantation
脐带血造血干细胞移植
2) Umbilical cord blood transplantation
脐带造血干细胞移植
1.
Objective To explore common causes of death in umbilical cord blood transplantation treating malignant and nonmalignant diseases in children.
目的探讨脐带造血干细胞移植治疗儿童恶性或非恶性疾病后患儿的常见死亡原因。
5) UCB-HSC
脐带血造血干细胞
1.
Objective:Previous studies have shown that allogeneic umbilical cord blood hematopoietic stem cells(UCB-HSCs) were demonstrated to be able to engraft into a host with intact innate immunity.
目的:近年来有研究发现异基因脐带血造血干细胞(UCB-HSCs)能够在免疫功能正常的受者体内长期存活。
6) hematopoietic stem cell transplantation
造血干细胞移植
1.
Clinical studies of unrelated donor hematopoietic stem cell transplantation for patients with hematologic malignant diseases;
无血缘关系供者造血干细胞移植治疗恶性血液病的临床研究
2.
Correlation between blood concentrations of ciclosporin and its adverse drug reactions in immunosuppressive treatment of hematopoietic stem cell transplantation recipients;
造血干细胞移植中环孢素血药浓度与其不良反应的相关性研究
3.
Reviews of the Research on Hematopoietic Stem Cell Transplantation of Multiple Myeloma;
造血干细胞移植治疗多发性骨髓瘤的研究进展
补充资料：造血干细胞刺激因子
造血干细胞刺激因子
hemopoietic sti?mulating factor,CSF
诱导辅助细胞释放CSF，进而活化干细胞，可明显升高白细胞水平，用基因重组产生的CSF-1可活化巨噬细胞杀肿瘤活性，刺激单核细胞产生干扰素，肿瘤坏死因子可刺激造血细胞增生，促进细胞成熟和功能活化等，有临床应用价值。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条